Samumed Announces Publication of Phase 2 Data on Lorecivivint, Now in Pivotal Trials for Knee Osteoarthritis

    NEXT STORY
    Generex Subsidiary NGIO Advances COVID-19 Vaccine Program with the Manufacturing of Patent-Pending Ii-Key-SARS-CoV-2 Peptides
    PREV STORY
    Checkpoint Therapeutics to Host Virtual Annual Meeting of Stockholders
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Castle Connolly Medical Ltd. Continues to Expand Its Database of Top Doctors Across the U.S.

    New York, NY, May 15, 2018 (GLOBE NEWSWIRE) -- Castle Connolly Medical Ltd. (www.castleconnolly.com) ...

    author_avatar
    NASDAQ Market News

    Inaugural Medical Capital Innovation Competition Winners Announced

    CLEVELAND, April 26, 2017 (GLOBE NEWSWIRE) -- Cuyahoga County, BioEnterprise, HIMSS (Healthcare Information and ...

    author_avatar
    NASDAQ Market News

    PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update

    author_avatar
    NASDAQ Market News